From the late 1990s through the early 2010s, Las Vegas Sands (NYSE:LVS) was one of the best growth companies in the gaming industry. It expanded in Las Vegas, Macau, and Singapore, becoming the largest publicly traded gaming company in the world.
Today, investors looking at the casino resort operator don’t see a growth company at all, and they shouldn’t. It has transitioned into a cash-flow machine, and that’s why I think it’s time to look at Las Vegas Sands’ dividend as a great buy in the gaming industry.
The growth days are over… and that’s OK
Las Vegas Sands was in expansion mode from the time The Venetian Las Vegas opened in 1999 until The Parisian in Macau was completed in 2016. Throughout that period, the company was constantly planning or building new resorts. But there aren’t any new projects on the horizon now, and Las Vegas Sands has entered a phase of its life where it may not grow at all.
Top Casino Stocks To Invest In Right Now: First Majestic Silver Corp.(AG)
Advisors’ Opinion:
- [By Joseph Griffin]
First Majestic Silver Corp. (NYSE:AG) (TSE:FR)’s share price gapped down prior to trading on Friday . The stock had previously closed at $5.88, but opened at $5.73. First Majestic Silver shares last traded at $5.70, with a volume of 4362990 shares traded.
- [By Neha Chamaria]
Shares of First Majestic Silver (NYSE:AG) slumped 15.9% last month, according to data provided by S&P Global Market Intelligence. The stock had a heady run-up between February and June before it reversed course. By far, August turned out to be its worst month so far this year.
- [By Logan Wallace]
These are some of the media stories that may have effected Accern Sentiment’s scoring:
Get First Majestic Silver alerts:
Zacks: Analysts Anticipate First Majestic Silver Corp. (AG) Will Announce Earnings of $0.03 Per Share (americanbankingnews.com) News Report of Sizzling Basic materials Stock: First Majestic Silver Corp. (AG) (nasdaqplace.com) Stock in the Wall Street Spotlight: First Majestic Silver Corp. (AG) (nysewired.com) Is the Stock Overvalued? – First Majestic Silver Corp. (NYSE:AG) (nasdaqjournal.com) Stocks in the Spotlight: Oasis Petroleum Inc. (NYSE:OAS), Bloomin’ Brands, Inc. (NASDAQ:BLMN), First Majestic Silver … (journalfinance.net)
Shares of First Majestic Silver opened at $7.30 on Friday, MarketBeat.com reports. First Majestic Silver has a 12-month low of $4.93 and a 12-month high of $8.73. The company has a market capitalization of $1.41 billion, a P/E ratio of -182.50 and a beta of 0.30. The company has a debt-to-equity ratio of 0.21, a current ratio of 4.41 and a quick ratio of 4.15.
- [By Shane Hupp]
First Majestic Silver Corp. (TSE:FR) (NYSE:AG) Director Robert A. Mccallum sold 2,000 shares of the stock in a transaction that occurred on Monday, August 20th. The shares were sold at an average price of C$6.94, for a total transaction of C$13,880.00.
- [By Sean Williams]
Next, you might be wondering what exactly would be considered “cheap” if analyzing cash flow per share. Though it’s going to be up to interpretation, after many years of tracking precious-metal stocks, I’m of the belief that a mining stock valued at 10 times its annual CFPS is considered fairly valued, with a slightly higher multiple for precious-metal royalty and streaming companies. With this in mind, here’s why SSR Mining (NASDAQ:SSRM) and First Majestic Silver (NYSE:AG) are currently the top two holdings in my portfolio.
Top Casino Stocks To Invest In Right Now: Home BancShares, Inc.(HOMB)
Advisors’ Opinion:
- [By Logan Wallace]
BNP Paribas Arbitrage SA cut its stake in Home Bancshares Inc (NASDAQ:HOMB) by 61.5% during the first quarter, HoldingsChannel.com reports. The fund owned 51,186 shares of the financial services provider’s stock after selling 81,923 shares during the quarter. BNP Paribas Arbitrage SA’s holdings in Home Bancshares were worth $1,168,000 as of its most recent SEC filing.
- [By Max Byerly]
BidaskClub cut shares of Home BancShares (NASDAQ:HOMB) from a hold rating to a sell rating in a research report report published on Wednesday morning.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Home Bancshares (HOMB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Zeke Capital Advisors LLC purchased a new stake in shares of Home BancShares (NASDAQ:HOMB) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 8,987 shares of the financial services provider’s stock, valued at approximately $205,000.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Home Bancshares (HOMB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Headlines about Home BancShares (NASDAQ:HOMB) have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Home BancShares earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave media headlines about the financial services provider an impact score of 45.7100995172055 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Top Casino Stocks To Invest In Right Now: Akebia Therapeutics, Inc.(AKBA)
Advisors’ Opinion:
- [By WWW.GURUFOCUS.COM]
For the details of Novo A’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Novo+A
These are the top 5 holdings of Novo AInogen Inc (INGN) – 3,549,320 shares, 59.83% of the total portfolio. Acceleron Pharma Inc (XLRN) – 1,553,937 shares, 9.34% of the total portfolio. Dermira Inc (DERM) – 1,984,364 shares, 7.81% of the total portfolio. Shares added by 3.27%Corvus Pharmaceuticals Inc (CRVS) – 3,244,046 shares, 4.76% of the total portfolio. Akebia Therapeutics Inc (AKBA) – 2,225,000 shares, 4
- [By Stephan Byrd]
PNC Financial Services Group Inc. grew its holdings in shares of Akebia Therapeutics Inc. (NASDAQ:AKBA) by 653,850.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 313,896 shares of the biopharmaceutical company’s stock after buying an additional 313,848 shares during the quarter. PNC Financial Services Group Inc. owned 0.55% of Akebia Therapeutics worth $2,991,000 at the end of the most recent quarter.
- [By Shane Hupp]
Media coverage about Akebia Therapeutics (NASDAQ:AKBA) has been trending somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Akebia Therapeutics earned a media sentiment score of 0.06 on Accern’s scale. Accern also gave headlines about the biopharmaceutical company an impact score of 47.5573804215754 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
- [By Max Byerly]
ValuEngine upgraded shares of Akebia Therapeutics (NASDAQ:AKBA) from a sell rating to a hold rating in a report released on Thursday.
Other equities research analysts have also recently issued reports about the company. Royal Bank of Canada reissued a hold rating and set a $13.00 price objective on shares of Akebia Therapeutics in a research note on Thursday, August 9th. Zacks Investment Research raised Akebia Therapeutics from a sell rating to a hold rating and set a $12.00 target price on the stock in a research note on Monday, May 14th. Mizuho reaffirmed a buy rating and set a $24.00 target price on shares of Akebia Therapeutics in a research note on Thursday, May 10th. Needham & Company LLC cut their target price on Akebia Therapeutics from $20.00 to $18.00 and set a buy rating on the stock in a research note on Friday, August 10th. Finally, HC Wainwright cut their target price on Akebia Therapeutics from $24.00 to $22.00 and set a buy rating on the stock in a research note on Wednesday, June 6th. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has an average rating of Buy and an average target price of $19.97.
- [By Brian Feroldi]
In response to the companies signing a merger agreement, shares of Akebia Therapeutics (NASDAQ:AKBA) and Keryx Biopharmaceuticals (NASDAQ:KERX) fell 18% and 12%, respectively, as of 10:47 a.m. EDT on Thursday.
Top Casino Stocks To Invest In Right Now: Tanger Factory Outlet Centers Inc.(SKT)
Advisors’ Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Tanger Factory Outlet Centers (SKT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Matthew Frankel]
Tanger Factory Outlet Centers (NYSE:SKT) has performed quite poorly lately. After a 7% drop following its first-quarter earnings release, the stock has now underperformed the S&P 500 by a staggering 69 percentage points over the past two years.
- [By Motley Fool Staff]
In this week’s installment of “One to Watch,” Fool.com contributor Matt Frankel, CFP, explains why retail real estate investment trust Tanger Factory Outlet Centers (NYSE:SKT) is at the top of his watchlist. And, host Jason Moser suggests that listeners keep an eye on Ellie Mae (NYSE:ELLI) — just hours before it announced it was being acquired!
- [By Keith Noonan, Leo Sun, and Maxx Chatsko]
We asked three Motley Fool contributors each to identify a top income-paying company that’s primed to deliver strong returns for shareholders. Here’s why WestRock (NYSE:WRK), Tanger Factory Outlet Centers (NYSE:SKT), and AT&T (NYSE:T) made their list of dividend stocks that in-the-know investors should add to their portfolios.
Top Casino Stocks To Invest In Right Now: Dow Treasuries(DV)
Advisors’ Opinion:
- [By Motley Fool Transcribing]
Adtalem Global Education Inc. (NYSE:DV) Q2 2019 Earnings Conference CallFeb. 7, 2019 5:00 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:Operator
Top Casino Stocks To Invest In Right Now: Guggenheim S&P MidCap 400 Pure Gr ETF (RFG)
Advisors’ Opinion:
- [By Max Byerly]
Invesco S&P MidCap 400 Pure Growth ETF (NYSEARCA:RFG) announced a quarterly dividend on Monday, September 24th, Wall Street Journal reports. Investors of record on Tuesday, September 25th will be given a dividend of 0.5521 per share on Friday, September 28th. This represents a $2.21 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Monday, September 24th. This is a boost from Invesco S&P MidCap 400 Pure Growth ETF’s previous quarterly dividend of $0.26.